摘要
在南亚,斯里兰卡意味着快速老化,在2011年,13%的人口超过60岁,而在印度则是8%。对斯里兰卡人口大多数的遗传研究已经证实了其在印度大陆的起源。因为在这两个国家老化细胞骨架的病理与他们密切的遗传关系资料不足,所以我们对老年人进行了比较。50个来自科伦坡斯里兰卡的尸检脑标本(平均年龄72.1岁±7.8,平均±SD)和42个来自印度班加罗尔(平均年龄65.9岁±9.3)采用免疫组织化学技术筛选神经退行性病变。根据不完整的临床病史统计有79例(科伦坡- 47和班加罗尔- 32)进行统计分析,并且13例,临床诊断为痴呆症和/或帕金森疾病的患者被排除。根据国家研究所老年-阿尔茨海默氏症协会指南,在科伦坡和班加罗尔样品之间,阿尔茨海默病的神经病理变化中/高水平为4.25%和3.12%,低水平分别为19.15%和15.62%。与帕金森包括脑干主导Lewy小体- 6.4%和可能的渐进超核麻痹2.13%科伦坡样品仅发现相关的病症。老年痴呆症相关的老年人疾病并没有不同,在科伦坡的男性,神经原纤维缠结极显著高于海马区(让步比= 1.46,95%可信区间为0.07-0.7)在中脑黑质的风险(P = 0.075)。其他与年龄有关的疾病,包括海绵状变化(P<0.05)和齿状回区海马细胞的损失(P<0.05)也被醒目地标识在科伦坡的样品。总之,衰老细胞骨架病变是老年斯里兰卡人相对较高,这可能是由于遗传、饮食或环境的变化。
关键词: AD的神经病理学改变,细胞丢失,免疫组织化学,帕金森,南亚,海绵状改变。
Current Alzheimer Research
Title:Cytoskeletal Pathologies of Age-Related Diseases between Elderly Sri Lankan (Colombo) and Indian (Bangalore) Brain Samples
Volume: 13 Issue: 3
Author(s): Printha Wijesinghe, S. K. Shankar, Yasha T. Chickabasaviah, Catherine Gorrie, Dhammika Amaratunga, Sanjayah Hulathduwa and K. Sunil Kumara, Kamani Samarasinghe, Yoo Hun Suh, H. W. Steinbusch, K. Ranil D. De Silva
Affiliation:
关键词: AD的神经病理学改变,细胞丢失,免疫组织化学,帕金森,南亚,海绵状改变。
摘要: Within South Asia, Sri Lanka represents fastest aging with 13% of the population was aged over 60’s in 2011, whereas in India it was 8%. Majority of the Sri Lankan population based genetic studies have confirmed their origin on Indian mainland. As there were inadequate data on aging cytoskeletal pathologies of these two nations with their close genetic affiliations, we performed a comparison on their elderly. Autopsy brain samples of 50 individuals from Colombo, Sri Lanka (mean age 72.1yrs ± 7.8, mean ± S.D.) and 42 individuals from Bangalore, India (mean age 65.9yrs ± 9.3) were screened for neurodegenerative pathologies using immunohistochemical techniques. A total of 79 cases with incomplete clinical history (Colombo- 47 and Bangalore- 32) were subjected to statistical analysis and 13 cases, clinically diagnosed with dementia and/or Parkinsonism disorders were excluded. As per National Institute on Aging- Alzheimer’s Association guidelines, between Colombo and Bangalore samples, Alzheimer’s disease neuropathologic change for intermediate/ high level was 4.25% vs. 3.12% and low level was 19.15% vs. 15.62% respectively. Pathologies associated with Parkinsonism including brainstem predominant Lewy bodies- 6.4% and probable progressive supra nuclear palsy- 2.13% were found solely in Colombo samples. Alzheimer related pathologies were not different among elders, however, in Colombo males, neurofibrillary tangle grade was significantly higher in the region of hippocampus (odds ratio = 1.46, 95% confidence interval = 0.07-0.7) and at risk in midbrain substantia nigra (p = 0.075). Other age-related pathologies including spongiform changes (p < 0.05) and hippocampus cell loss in dentate gyrus region (p < 0.05) were also identified prominently in Colombo samples. Taken together, aging cytoskeletal pathologies are comparatively higher in elderly Sri Lankans and this might be due to their genetic, dietary and/ or environmental variations.
Export Options
About this article
Cite this article as:
Printha Wijesinghe, S. K. Shankar, Yasha T. Chickabasaviah, Catherine Gorrie, Dhammika Amaratunga, Sanjayah Hulathduwa and K. Sunil Kumara, Kamani Samarasinghe, Yoo Hun Suh, H. W. Steinbusch, K. Ranil D. De Silva , Cytoskeletal Pathologies of Age-Related Diseases between Elderly Sri Lankan (Colombo) and Indian (Bangalore) Brain Samples, Current Alzheimer Research 2016; 13 (3) . https://dx.doi.org/10.2174/156720501303160217121210
DOI https://dx.doi.org/10.2174/156720501303160217121210 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Melatonin and Its Therapeutic Potential in Neuroprotection
Central Nervous System Agents in Medicinal Chemistry Grey Matter Atrophy in Mild Cognitive Impairment / Early Alzheimer Disease Associated with Delusions: A Voxel-Based Morphometry Study
Current Alzheimer Research Pharmacological Approaches to Chronic Spinal Cord Injury
Current Pharmaceutical Design Serotonin and Human Cognitive Performance
Current Pharmaceutical Design Start Small and Stay Small: Minimizing Attrition in the Clinic with a Focus on CNS Therapeutics
Current Topics in Medicinal Chemistry Editorial - Progress of Current Alzheimer Research
Current Alzheimer Research Characterization of Serum Exosomes from a Transgenic Mouse Model of Alzheimer’s Disease
Current Alzheimer Research A Synthesis of Functional Neuroimaging in the Frontal Variant of Frontotemporal Dementia
Current Medical Imaging HIV-1 Subtypes B and C Tat Differentially Impact Synaptic Plasticity Expression and Implicates HIV-Associated Neurocognitive Disorders§
Current HIV Research Development of HIV Reservoir Targeted Long Acting Nanoformulated Antiretroviral Therapies
Current Medicinal Chemistry Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder
Current Neuropharmacology Molecular Modelling Approaches to the Design of Acetylcholinesterase Inhibitors: New Challenges for the Treatment of Alzheimers Disease
Current Pharmaceutical Design Data Tagging in Medical Images: A Survey of the State-of-Art
Current Medical Imaging Amyloid-Related Biomarkers for Alzheimers Disease
Current Medicinal Chemistry Elevated Aβ42 in Aged, Non-demented Individuals with Cerebral Atherosclerosis
Current Alzheimer Research Potential Enzymatic Targets in Alzheimer’s: A Comprehensive Review
Current Drug Targets Sleep Related Disorders in the Elderly: An Overview
Current Respiratory Medicine Reviews Citalopram-Associated Alopecia: A Case Report and Brief Literature Review
Current Drug Safety Adrenergic Drugs Blockers or Enhancers for Cognitive Decline ? What to Choose for Alzheimer’s Disease Patients?
CNS & Neurological Disorders - Drug Targets Biochemical Properties of Indoleamine 2,3-dioxygenase: From Structure to Optimized Design of Inhibitors
Current Medicinal Chemistry